1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Clinical Research Network on Antimicrobial Resistance (AMR) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This program aims to design, implement, and manage clinical research addressing key clinical questions in antimicrobial resistance (AMR), focusing on bacterial and fungal infections.
Areas of emphasis include clinical testing of new antibiotics and other treatments, optimizing existing antibiotic use, evaluating novel diagnostic tests, and mentoring future AMR clinical researchers.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Clinical Research Network on Antimicrobial Resistance Clinical Research Network on Antimicrobial Resistance Agency: National Institutes of Health Assistance Listings: 93. 855 -- Allergy and Infectious Diseases Research Last Updated: May 13, 2026 View version history on Grants.
gov The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for a Clinical Research Network on Antimicrobial Resistance (AMR). AMR is a major health challenge that limits treatment options and allows resistant infections to persist.
Individuals with chronic conditions like diabetes and cancer are particularly vulnerable, resulting in increased illness and death as well as higher healthcare costs in the United States. The program aims to design, implement, and manage clinical research addressing key clinical questions in AMR. Research will focus on bacterial and fungal infections associated with AMR.
Areas of emphasis include clinical testing of new antibiotics and other treatments such as bacteriophage therapy, methods optimizing the use of existing antibiotics, evaluating novel diagnostic tests including using diagnostics to refine treatment strategies, and mentoring the next generation of AMR clinical researchers.
Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Other Native American tribal organizations Nonprofits non-higher education without 501(c)(3) Nonprofits non-higher education with 501(c)(3) For-profit organizations other than small businesses Special district governments City or township governments Public and state institutions of higher education Private institutions of higher education Other Eligible ApplicantsFaith-based or Community-based Organizations;Regional Organizations Grantor contact information Division of Microbiology and Infectious Diseases Please contact via e-mail.
AMRClinicalResearchNetworkContact@mail. nih. gov AMRClinicalResearchNetworkContact@mail.
nih. gov No documents are currently available. Link to additional information Estimated Application Due Date : Estimated Due Date Description : Estimated Project Start Date : Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: City or township governments, Native American tribal organizations (other than Federally recognized tribal governments), For-profit organizations other than small businesses, Nonprofits that do not have a 501(c)(3) status with the IRS (other than institutions of higher education), Small businesses, Special district governments, Public and State controlled institutions of higher education, Nonprofits having a 501(c)(3) status with the IRS (other than institutions of higher education), Private institutions of higher education, Faith-based or Community-based Organizations, Regional Organizations. Confirm the full requirements in the official notice before applying.
The current listing shows $15,000,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Clinical Research Network on Antimicrobial Resistance (AMR) are due September 29, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Clinical Research Network on Antimicrobial Resistance (AMR) is funded by National Institute of Allergy and Infectious Diseases (NIAID). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleThe ReVAMPP network funds vaccine and monoclonal antibody research across five virus families. Here is who won, what the prototype-pathogen strategy means, and how to position for the next round.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read article